KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) FCF Margin (2019 - 2025)

GoodRx Holdings' FCF Margin history spans 7 years, with the latest figure at 43.78% for Q4 2025.

  • For Q4 2025, FCF Margin rose 5551.0% year-over-year to 43.78%; the TTM value through Dec 2025 reached 20.63%, up 614.0%, while the annual FY2025 figure was 20.63%, 614.0% up from the prior year.
  • FCF Margin for Q4 2025 was 43.78% at GoodRx Holdings, up from 30.49% in the prior quarter.
  • Across five years, FCF Margin topped out at 62.97% in Q3 2024 and bottomed at 13.49% in Q2 2024.
  • The 5-year median for FCF Margin is 15.34% (2021), against an average of 17.61%.
  • The largest YoY upside for FCF Margin was 5551bps in 2025 against a maximum downside of -3248bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 11.11% in 2021, then skyrocketed by 213bps to 34.77% in 2022, then crashed by -77bps to 8.07% in 2023, then crashed by -245bps to 11.73% in 2024, then surged by 473bps to 43.78% in 2025.
  • Per Business Quant, the three most recent readings for GDRX's FCF Margin are 43.78% (Q4 2025), 30.49% (Q3 2025), and 4.96% (Q2 2025).